Senseonics Holdings (SENS)

Feb 13, 2025, 4:05 PM EST - 9 days ago

Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 6, 2025, 4:05 PM EST - 16 days ago

Senseonics Completes CE Mark Submission for Eversense 365, World's Longest-lasting Continuous Glucose Monitor

Jan 8, 2025, 6:12 PM EST - 6 weeks ago

Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting

Nov 7, 2024, 6:33 PM EST - 3 months ago

Senseonics Holdings, Inc. (SENS) Q3 2024 Earnings Call Transcript

Oct 16, 2024, 4:30 PM EDT - 4 months ago

Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System

Oct 10, 2024, 4:10 PM EDT - 4 months ago

Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor

Oct 1, 2024, 11:00 AM EDT - 5 months ago

Eversense 365 Launches in the US: One Year. One CGM.

Sep 17, 2024, 7:00 AM EDT - 5 months ago

Eversense 365 Receives FDA Clearance: The World's First One Year CGM

Sep 6, 2024, 4:05 PM EDT - 6 months ago

Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference

Aug 8, 2024, 6:07 PM EDT - 7 months ago

Senseonics Holdings, Inc. (SENS) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:05 PM EDT - 7 months ago

Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results

Jul 25, 2024, 4:05 PM EDT - 7 months ago

Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time

Jun 21, 2024, 4:05 PM EDT - 8 months ago

Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook

Jun 13, 2024, 4:05 PM EDT - 9 months ago

Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association's 84th Scientific Sessions

May 29, 2024, 4:05 PM EDT - 9 months ago

Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference

May 13, 2024, 7:52 PM EDT - 10 months ago

Senseonics Holdings, Inc. (SENS) Q1 2024 Earnings Call Transcript

May 13, 2024, 4:05 PM EDT - 10 months ago

Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results

May 13, 2024, 4:04 PM EDT - 10 months ago

Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management

May 9, 2024, 4:05 PM EDT - 10 months ago

Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution

May 2, 2024, 8:05 AM EDT - 10 months ago

Senseonics Holdings, Inc. to Participate in Upcoming Conferences

Apr 30, 2024, 4:05 PM EDT - 10 months ago

Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time

Apr 30, 2024, 7:00 AM EDT - 10 months ago

Eversense® CGM System Receives iCGM Designation by the US FDA

Mar 12, 2024, 7:00 AM EDT - 1 year ago

SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS

Mar 8, 2024, 8:05 AM EST - 1 year ago

Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes

Mar 6, 2024, 8:05 AM EST - 1 year ago

Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference

Feb 29, 2024, 7:34 PM EST - 1 year ago

Senseonics Holdings, Inc. (SENS) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 4:05 PM EST - 1 year ago

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 15, 2024, 4:05 PM EST - 1 year ago

Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time

Feb 12, 2024, 7:00 AM EST - 1 year ago

Medicare Coverage Significantly Expanded for the Eversense E3 CGM System

Feb 12, 2024, 7:00 AM EST - 1 year ago

MEDICARE COVERAGE SIGNIFICANTLY EXPANDED FOR THE EVERSENSE E3 CGM SYSTEM

Feb 6, 2024, 8:00 AM EST - 1 year ago

PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care

Jan 2, 2024, 4:05 PM EST - 1 year ago

Senseonics Holdings, Inc. Announces Business Updates

Nov 9, 2023, 6:50 PM EST - 1 year ago

Senseonics Holdings, Inc. (SENS) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 4:05 PM EST - 1 year ago

Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results

Nov 9, 2023, 8:05 AM EST - 1 year ago

Senseonics Holdings, Inc. to Participate in the Stifel 2023 Healthcare Conference

Oct 30, 2023, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc Schedules Third Quarter 2023 Earnings Release and Conference Call for November 9, 2023 at 4:30 p.m. Eastern Time

Oct 9, 2023, 7:00 AM EDT - 1 year ago

Ascensia Diabetes Care and Senseonics Announce ‘The CGM for Real Life' Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes

Sep 26, 2023, 8:05 AM EDT - 1 year ago

Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study

Sep 14, 2023, 8:05 AM EDT - 1 year ago

Senseonics Holdings, Inc. to Participate in the Gilmartin Group Emerging Growth Company Showcase

Sep 11, 2023, 8:05 AM EDT - 1 year ago

Senseonics Holdings, Inc. Enters Into $50 Million Loan Facility With Hercules Capital

HTGC

Aug 10, 2023, 6:29 PM EDT - 1 year ago

Senseonics Holdings, Inc. (SENS) Q2 2023 Earnings Call Transcript

Aug 10, 2023, 4:15 PM EDT - 1 year ago

Senseonics Holdings, Inc. Reports Second Quarter 2023 Financial Results

Jul 27, 2023, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 10, 2023 at 4:30 p.m. Eastern Time

Jul 5, 2023, 4:05 PM EDT - 1 year ago

Senseonics Announces Equity Grants To Employees Under Inducement Plan

Jun 26, 2023, 7:30 AM EDT - 1 year ago

New Clinical Data Demonstrating the Safety and Accuracy of Eversense through 365 Days Presented at the American Diabetes Association 83rd Scientific Sessions

Jun 2, 2023, 8:34 AM EDT - 1 year ago

Senseonics shares jump 6.7% on new insurance coverage for continuous glucose monitor

Jun 2, 2023, 7:00 AM EDT - 1 year ago

Senseonics Announces UnitedHealthcare Coverage of Eversense® E3 CGM for Adults with Diabetes

May 26, 2023, 7:00 AM EDT - 1 year ago

Senseonics to Participate in the Jefferies Healthcare Conference

May 9, 2023, 6:36 PM EDT - 1 year ago

Senseonics Holdings, Inc. (SENS) Q1 2023 Earnings Call Transcript

May 9, 2023, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. Reports First Quarter 2023 Financial Results